Assessing the cumulative effects of disease-modifying therapies on the current risk of irreversible disability in patients with relapsing-remitting multiple sclerosis - Département Méthodes quantitatives en santé publique Accéder directement au contenu
Article Dans Une Revue Multiple Sclerosis Journal Année : 2018

Assessing the cumulative effects of disease-modifying therapies on the current risk of irreversible disability in patients with relapsing-remitting multiple sclerosis

Fichier non déposé

Dates et versions

hal-01935071 , version 1 (26-11-2018)

Identifiants

  • HAL Id : hal-01935071 , version 1

Citer

F. Rollot, Romain Casey, Marc Debouverie, Gilles Edan, S. Wiertlewski, et al.. Assessing the cumulative effects of disease-modifying therapies on the current risk of irreversible disability in patients with relapsing-remitting multiple sclerosis. Multiple Sclerosis Journal, 2018, 24, pp.344-345. ⟨hal-01935071⟩
75 Consultations
0 Téléchargements

Partager

Gmail Facebook X LinkedIn More